Singleton, D. C., Dechaume, A., Murray, P. M., Katt, W. P., Baguley, B. C., & Leung, E. Y. (2020). Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer. BMC Cancer.
Citación estilo ChicagoSingleton, Dean C., Anne-Lise Dechaume, Pamela M. Murray, William P. Katt, Bruce C. Baguley, and Euphemia Y. Leung. "Pyruvate Anaplerosis Is a Mechanism of Resistance to Pharmacological Glutaminase Inhibition in Triple-receptor Negative Breast Cancer." BMC Cancer 2020.
Cita MLASingleton, Dean C., et al. "Pyruvate Anaplerosis Is a Mechanism of Resistance to Pharmacological Glutaminase Inhibition in Triple-receptor Negative Breast Cancer." BMC Cancer 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.